Quotient Sciences
Updates & Highlights
Revelio Labs · about 1 month ago
Quotient Sciences Number of Employees 2026 | Employee Count & Headcount Data
MarketScale · 3 months ago
Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic
PR Newswire UK · 3 months ago
Quotient Sciences Advances AI-Designed Drug Product into Clinical Development
Recent Openings
View all 1 jobs arrow_forwardAll Jobs
Culture & Mission
Benefits & Perks
Learning Budget
Professional development
Competitive Salary
Market-rate compensation
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Generous PTO
Paid time off
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Quotient Sciences?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentQuotient Sciences Number of Employees 2026 | Employee Count & Headcount Data
Quotient Sciences Number of Employees 2026 | Employee Count & Headcount Data
Revelio Labs · about 1 month ago
Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic
Quotient Sciences launches Phase I trial of what it calls the first AI-formulated drug to reach the clinic
MarketScale · 3 months ago
Quotient Sciences Advances AI-Designed Drug Product into Clinical Development
Quotient Sciences Advances AI-Designed Drug Product into Clinical Development
PR Newswire UK · 3 months ago
Quotient Sciences advances AI-designed drug product into Phase I clinical study
Quotient Sciences advances AI-designed drug product into Phase I clinical study
Indian Pharma Post · 3 months ago
Quotient Sciences Advances AI-Designed Drug Product into Clinical Development
Quotient Sciences Advances AI-Designed Drug Product into Clinical Development
PR Newswire · 3 months ago
Quotient Sciences advances AI-designed drug product into Phase I clinical study
Quotient Sciences advances AI-designed drug product into Phase I clinical study
Indian Pharma Post · 4 months ago
How many employees work at Quotient Sciences?
How many employees work at Quotient Sciences?
Revelio Labs · 5 months ago
Quotient Sciences Extends Partnership with Ipsen for Manufacture of Ultra-Rare Disease Treatment
Quotient Sciences Extends Partnership with Ipsen for Manufacture of Ultra-Rare Disease Treatment
PharmTech.com · 6 months ago
Quotient Sciences, Ipsen Extend Commercial Manufacturing Pact
Quotient Sciences, Ipsen Extend Commercial Manufacturing Pact
Contract Pharma · 7 months ago
Lindus Health, Quotient Sciences Partner to Accelerate Drug Development to Clinical Trials
Lindus Health, Quotient Sciences Partner to Accelerate Drug Development to Clinical Trials
Contract Pharma · 9 months ago
Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
PharmaTimes · 9 months ago
Lindus Health and Quotient Sciences to support sponsors with trial recruitment
Lindus Health and Quotient Sciences to support sponsors with trial recruitment
Clinical Trials Arena · 9 months ago
Lindus Health and Quotient Sciences Partner to Accelerate Drug Development from First-in-Human to Pivotal Trials
Lindus Health and Quotient Sciences Partner to Accelerate Drug Development from First-in-Human to Pivotal Trials
PR Newswire · 9 months ago
Quotient Sciences, Intrepid Labs Partner to Advance AI in Early Drug Development
Quotient Sciences, Intrepid Labs Partner to Advance AI in Early Drug Development
Contract Pharma · 9 months ago
Quotient Sciences, Biorasi form partnership for early phase trials
Quotient Sciences, Biorasi form partnership for early phase trials
Clinical Trials Arena · 11 months ago
Quotient Sciences and Biorasi partner to accelerate early phase clinical trials to patient proof-of-concept
Quotient Sciences and Biorasi partner to accelerate early phase clinical trials to patient proof-of-concept
PR Newswire · 11 months ago
Drug Development Firm Quotient Sciences Faces Market Pressures
Drug Development Firm Quotient Sciences Faces Market Pressures
Manufacturing Management · 11 months ago
Quotient Sciences and CPI Partner to Enhance RNA Therapy Development and Production Efficiency
Quotient Sciences and CPI Partner to Enhance RNA Therapy Development and Production Efficiency
geneonline.com · about 1 year ago
Quotient Sciences and CPI to expedite RNA therapy development
Quotient Sciences and CPI to expedite RNA therapy development
Pharmaceutical Technology · about 1 year ago
Quotient Sciences, CPI Form RNA Drug Development Joint Venture
Quotient Sciences, CPI Form RNA Drug Development Joint Venture
Contract Pharma · about 1 year ago